Cleared Traditional

K871324 - DU PONT STERICELL CELL CULTURE SYSTEM (FDA 510(k) Clearance)

Class I Pathology device.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
11d
Days
Class 1
Risk

K871324 is an FDA 510(k) clearance for the DU PONT STERICELL CELL CULTURE SYSTEM. Classified as Flask, Tissue Culture (product code KJA), Class I - General Controls.

Submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on April 14, 1987 after a review of 11 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.2240 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E.I. Dupont DE Nemours & Co., Inc. devices

Submission Details

510(k) Number K871324 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 1987
Decision Date April 14, 1987
Days to Decision 11 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 77d · This submission: 11d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KJA Flask, Tissue Culture
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.2240
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.